Puberty Suppression in Transgender and Gender-Diverse Adolescents: Timely Care for Optimal Outcomes.

In this perspective, we argue that pubertal suppression with gonadotropin-releasing hormone analogues is a safe reversible intervention that should be made available to transgender and gender-diverse youth starting at early puberty. Recent data suggest puberty suppression is generally initiated among individuals once puberty has significantly progressed, thus reducing the effectiveness of the intervention. Delays and barriers to such care may systematically introduce permanent avoidable disadvantages for this vulnerable and marginalized group.
Competing Interests: No competing financial interests exist.
(Copyright 2022, Mary Ann Liebert, Inc., publishers.)